Comparison of Diabetes diagnostic categories in the U.S. population according to 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria

Diabetes Care

Volumn 20, Issue 12, 1997, Pages 1859-1862

  Harris, Maureen I ^a   Eastman, Richard C ^a   Cowie, Catherine C ^a   Flegal, Katherine M ^b   Eberhardt, Mark S ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE CLASSIFICATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; POPULATION RESEARCH; WORLD HEALTH ORGANIZATION;

EID: 0030728401     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.12.1859     Document Type: Article

References (18)

1. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
2. World Health Organization: Second Report of the WHO Expert Committee on Diabetes Mellitus. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646)
3. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
4. American Diabetes Association: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183-1197, 1997
5. U.S. Department of Health and Human Services, National Center for Health Statistics: Third National Health and Nutrition Examination Survey, 1988-1994, Reference Manuals and Reports: Manual for Medical Technicians and Laboratory Procedures Used for NHANES III (CD-ROM). Hyattsville, MD, Centers for Disease Control and Prevention, 1996
6. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44:968-983, 1995
7. SAS Institute: SAS Procedures Guide, Version 6. 3rd ed. Cary, NC, SAS Institute, 1990
8. Day JC: Population Projections of the United States by Age, Race, and Hispanic Origin: 1995 to 2050. Washington, DC, U.S. Bureau of the Census, Current Population Reports, U.S. Govt. Printing Office, 1996 (P25-1130)
9. Shah BV, Bamwell BG, Bieler GS: SUDAAN User's Manual, Release 6.40. Research Triangle Park, NC, Research Triangle Institute, 1995
10. Olefsky JM, Reaven GM: Insulin and glucose responses to identical oral glucose tolerance tests performed forty-eight hours apart. Diabetes 23:449-453, 1974
11. Cummings ST, Fraser CG: Variability of capillary plasma glucose in healthy individuals in repeated 75 g oral glucose tolerance tests. Ann Clin Biochem 25:634-637, 1988
12. McPhillips JB, Barrett-Connor E, Wingard DL: Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol 131:443-453, 1990
13. Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK: Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes 39:283-288, 1990
14. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: The natural history of impaired glucose tolerance in Pima Indians. N Engl J Med 319:1500-1506, 1988
15. U.K. Prospective Diabetes Study Group: U.K. Prospective Diabetes Study 16: overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 44:1249-1258, 1995
16. Eastman RC, Javitt JC, Herman WH, Dasbach EJ, Copley-Merriman C, Maier W, Dong F, Manninen D, Zbrozek AS, Kotsanos J, Garfield SA, Harris M: Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normo-glycemia. Diabetes Care 20:735-744, 1997
17. Sowers JR: Impact of lipid and ACE inhibitor therapy on cardiovascular disease and metabolic abnormalities in the diabetic and hypertensive patient. J Hum Hypertens 11:9-16, 1997
18. Savage PJ: Cardiovascular complications of diabetes mellitus: what we know and what we need to know about their prevention. Ann Intern Med 124:123-126, 1996